Cargando…
The Role of Rituximab in Focal Segmental Glomerulosclerosis–Update From Italy
Autores principales: | Gauckler, Philipp, Kronbichler, Andreas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9366531/ https://www.ncbi.nlm.nih.gov/pubmed/35967101 http://dx.doi.org/10.1016/j.ekir.2022.06.002 |
Ejemplares similares
-
Focal Segmental Glomerulosclerosis: Genetics, Mechanism, and Therapies
por: Kronbichler, Andreas, et al.
Publicado: (2016) -
Rituximab treatment of adults with primary focal segmental glomerulosclerosis
por: Wang, Liuwei, et al.
Publicado: (2023) -
Immunologic Changes Implicated in the Pathogenesis of Focal Segmental Glomerulosclerosis
por: Kronbichler, Andreas, et al.
Publicado: (2016) -
Focal segmental glomerulosclerosis and end-stage kidney disease in children
por: Gheissari, Alaleh
Publicado: (2015) -
Successful treatment of adult-onset collapsing focal segmental glomerulosclerosis with rituximab
por: Ramachandran, Raja, et al.
Publicado: (2013)